Regulation and roles of elongation factor 2 kinase

Research output: Contribution to journalArticlepeer-review

72 Citations (Scopus)


Eukaryotic elongation factor 2 kinase (eEF2K) belongs to the small family of atypical protein kinases termed α-kinases, and is the only calcium/calmodulin (Ca/CaM)-dependent member of that group. It phosphorylates and inactivates eEF2, to slow down the rate of elongation, the stage in mRNA translation that consumes almost all the energy and amino acids consumed by protein synthesis. In addition to activation by Ca/CaM, eEF2K is also regulated by an array of other regulatory inputs, which include inhibition by the nutrient- and growth-factor activated signalling pathways. Recent evidence shows that eEF2K plays an important role in learning and memory, processes that require the synthesis of new proteins and involve Ca-mediated signalling. eEF2K is activated under conditions of nutrient and energy depletion. In cancer cells, or certain tumours, eEF2K exerts cytoprotective effects, which probably reflect its ability to inhibit protein synthesis, and nutrient consumption, under starvation conditions. eEF2K is being evaluated as a potential therapeutic target in cancer.

Original languageEnglish
Pages (from-to)328-332
Number of pages5
JournalBiochemical Society Transactions
Publication statusPublished or Issued - 1 Jun 2015


  • EEF2
  • MRNA translation
  • Nutrient
  • Protein synthesis
  • Synaptic plasticity
  • Tumour

ASJC Scopus subject areas

  • Biochemistry

Cite this